Predictors of Weight Loss and Metabolic Health After Bariatric Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
About this trial
In this prospective study the investigators aim to identify preoperative predictors of improvement of metabolic health and weight loss after bariatric surgery focusing on inflammation, insulin sensitivity (in a subgroup of patients), glucoregulatory determinants, psychological traits, feeding behavior characteristics and cardiorespiratory fitness
Eligibility criteria
Qualifiers
Ability to provide informed consent
Patient is ≥ 18 and ≤ 75 years old
BMI ≥ 40 kg/m2 or ≥ 35 kg/m2 with obesity related comorbidity
Scheduled for primary bariatric procedure: Roux-en-Y gastric bypass (RYGB) or Sleeve Gastrectomy (SG)
Disqualifiers
Any actual medical condition except for obesity related health issues or well treated hypothyroidism
Pregnancy anticipated in the first two years following surgery
Coagulation disorders and/or use anticoagulants
Use of any medication except for statins, antihypertensives (except for Angiotensine converting enzyme (ACE)- or angiotensin receptor blockers) and thyroid hormone
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead sponsor
Obesitas Kliniek B.V.
Collaborator
Radboud University Medical Center
Collaborator
Source ClinicalTrials.gov